Application no. and date | 18731976.9 (espacenet) (Federated) (European Patent Register), 20180605 | Patent/reg. no. and date | DK/EP 3634419, 20250129 | Publication date | 20200415 | Priority no. and date | US 201762515232 P, 20170605 | EP pub. no. and date |
EP 3634419 20200415 | Effective date | | Applicant/owner | Kissei Pharmaceutical Co., Ltd., 19-48, Yoshino
Matsumoto-Shi, Nagano 399-8710, JP | Applicant ref. no. | 6.2503.002 | Inventor | Gotteland, Jean-Pierre, 9 rue Charles Humbert
1205 Geneva, CH, LOUMAYE, Ernest, 29 Chemin de la Planta
1223 Cologny, CH, POHL, Oliver, c/o ObsEva S.A. Chemin des Aulx 12
1228 Plan-les-Ouates, CH | Representative | Holme Patent A/S, Valbygårdsvej 33, 1, 2500 Valby, DK | Opponent | | IPC Class | A61K 31/519 (2006.01) , A61P 15/00 (2006.01) | Title | Doseringsregime omfattende en gonadotropin-frigørende hormon-antagonist til behandling af fibromer i uterus og reduktion af menstruationsblodtab | Int. application no. | EP2018064767 | Int. publication no. | WO2018224497 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|